Foley Trasimene Acquisition II
Cash in trust
$1.5B
$1,467,439,625
Trust per share
$14.97
Redemption value
IPO
Aug 2020
—
Combination deadline
—
Not disclosed
Filings on record
57
Latest May 18, 2021
Business combination
- Target
- Not disclosed in an indexed filing
- Announced
- Dec 7, 2020
- Closed
- Mar 30, 2021
Overview
Foley Trasimene Acquisition II is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001818355. It completed its initial public offering in Aug 2020. The vehicle is sponsored by Trasimene Capital through Trasimene Capital FT, LP. The mandate targets technology. Business combination closed; the company trades under a new ticker.
“our strategy will be to identify, acquire and build a company in our target investment area, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.”
Reading the filings
Arithmetic on what Foley Trasimene Acquisition II has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trust versus the $10 unit
The trust holds $14.97 per public share, 49.7% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.
Warrant coverage
Each unit carried one-third of one warrant per unit. Warrants are dilution deferred: they cost the holder nothing until exercised, and they overhang the post-combination share count. Thinner coverage is generally a sign of a stronger book at pricing.
Underwriting
Credit Suisse led the offering. It has been named on 76 SPAC IPOs, book-running 57 of them, and 12% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
SEC filing history
Free tier: filings older than 24 hours- 10-K/A
FORM 10-K/A
Accession 0001104659-21-068955
- 8-K
Current report
Item 4.02 · Accession 0001104659-21-068954
- 15-12B
Deregistration of securities
Accession 0001193125-21-112590
- 25-NSE
Notification of delisting
Accession 0000876661-21-000476
- 4
Statement of changes in beneficial ownership
Accession 0000899243-21-013938
- 4
Statement of changes in beneficial ownership
Accession 0000899243-21-013937
- 4
Statement of changes in beneficial ownership
Accession 0000899243-21-013935
- 4
Statement of changes in beneficial ownership
Accession 0000899243-21-013932
- 8-K
Entry into a material definitive agreement; Completion of an acquisition; Notice of delisting or failure to satisfy a listing rule
Items 1.01, 2.01, 3.01, 3.02, 3.03, 5.01, 5.02, 5.03, 9.01 · Accession 0001193125-21-100484
- 8-K
Submission of matters to a vote of security holders; Other events
Items 5.07, 8.01, 9.01 · Accession 0001193125-21-094559
- 425
Business-combination communication
Accession 0001193125-21-094560
- 425
Business-combination communication
Accession 0001193125-21-092005
- 425
Business-combination communication
Accession 0001193125-21-085810
- 425
Business-combination communication
Accession 0001193125-21-085074
- 425
Business-combination communication
Accession 0001193125-21-080593
- 425
Business-combination communication
Accession 0001193125-21-079554
- 425
Business-combination communication
Accession 0001193125-21-073991
- 425
Business-combination communication
Accession 0001193125-21-071640
- DEFM14A
Definitive merger proxy statement
Accession 0001193125-21-060961
- 10-K
Annual report
Accession 0001104659-21-028432
- SC 13G
Beneficial ownership report (passive)
Accession 0001140361-21-004962
- SC 13G
SCHEDULE 13G FOR FOLEY TRASIMENE ACQUISITION II BY MFN PARTNERS MANAGEMENT LP, F
Accession 0000904454-21-000190
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001319244-21-000120
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0000902664-21-001163
- 425
Business-combination communication
Accession 0001193125-20-311998
- 425
Business-combination communication
Accession 0001193125-20-311938
- 425
Business-combination communication
Accession 0001193125-20-311837
- 425
Business-combination communication
Accession 0001193125-20-311898
- 425
Business-combination communication
Accession 0001193125-20-311876
- 425
Business-combination communication
Accession 0001193125-20-311887
Foley Trasimene Acquisition II: questions answered
What is Foley Trasimene Acquisition II?
Foley Trasimene Acquisition II is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001818355. It completed its initial public offering in Aug 2020. The vehicle is sponsored by Trasimene Capital through Trasimene Capital FT, LP. The mandate targets technology. Business combination closed; the company trades under a new ticker.
How much does Foley Trasimene Acquisition II hold in trust?
Approximately $1,467,439,625, or about $14.97 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Foley Trasimene Acquisition II complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Foley Trasimene Acquisition II does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Foley Trasimene Acquisition II, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $14.97 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for Foley Trasimene Acquisition II?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
How much dilution do Foley Trasimene Acquisition II's founder shares and warrants create?
Each unit also carried one-third of one warrant per unit, which is dilution deferred until exercise. Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.
Who sponsors Foley Trasimene Acquisition II, and what is their track record?
Trasimene Capital FT, LP is the sponsor entity, part of the Trasimene Capital franchise. This is the only vehicle we have attributed to that sponsor.
Which banks underwrote the Foley Trasimene Acquisition II IPO?
Credit Suisse, BofA Securities. Credit Suisse and BofA Securities were credited as book-running managers on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Foley Trasimene Acquisition II a good investment?
That is not a question this site answers. Foley Trasimene Acquisition II is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Foley Trasimene Acquisition II data come from?
Filings Foley Trasimene Acquisition II submitted to the SEC under CIK 0001818355: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Sep 4, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Trasimene Capital: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Credit Suisse in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Technology SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All completed de-spac transactions
Business combination closed; the company trades under a new ticker.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.